You are here: Industry Insights > Shingrix

News List

GlaxoSmithKline's Shingrix shortage expected to persist 'throughout 2019' fiercepharma
December 12, 2018
In the face of "unprecedented" demand for its shingles vaccine, GlaxoSmithKline is doing everything it can to boost supply. But in spite of those efforts—it shipped as much vaccine in the third quarter as it did in the first half of the year—GSK
GSK narrows earnings guidance after Shingrix boost pharmatimes
November 05, 2018
GSK says it now expects full-year earnings at the upper end of its guidance after continued sales growth during the third quarter and the delay to generic
GlaxoSmithKline's Shingrix zooms toward blockbuster status despite tight supply fiercepharma
November 01, 2018
GlaxoSmithKline's Shingrix zooms toward blockbuster status despite tight supply
China targets Cosentyx, Shingrix and Luxturna and 45 other drugs for priority approval fiercepharma
August 10, 2018
Hey, Big Pharma stars: China wants you. Aiming to speed new drugs to market, China just came up with a target list of 48 treatments greenlighted abroad, including some of the industry's biggest names.
GlaxoSmithKline's Shingrix beats expectations again in Q2 despite supply constraint fiercepharma
July 30, 2018
GlaxoSmithKline's hot shingles vaccine Shingrix has routinely beaten expectations since its U.S. rollout, and its second-quarter performance was no different....
GlaxoSmithKline's Shingrix beats expectations again in Q2 despite supply constraint fiercepharma
July 30, 2018
GlaxoSmithKline's hot shingles vaccine Shingrix has routinely beaten expectations since its U.S. rollout, and its second-quarter performance was no different.
GSK ups guidance and unveils major restructure pharmatimes
July 26, 2018
GlaxoSmithKline has upped its expectations for the year after a strong performance by its vaccines division in the second quarter and the delay of a potential generic version of Advair in the US.
Doctors worry Shingrix side effects will put patients off their second dose fiercevaccines
July 23, 2018
The CDC has urged people 50 and older to get GlaxoSmithKline's new shingles vaccine to protect against a notoriously painful condition. But amid the company's important launch, some doctors are worried patients won't return for their second dose if they e
Senators demand more from GlaxoSmithKline to boost Shingrix supply fiercevaccines
July 10, 2018
Amid high demand for GlaxoSmithKline's new shingles vaccine, healthcare providers are running out. Even though the company worked up what it calls a "fair and equitable" process to ship Shingrix doses
GlaxoSmithKline boosted Shingrix educational efforts after seeing administration, storage errors in launch fiercevaccines
June 26, 2018
Drug launches come with an array of challenges, and GlaxoSmithKline is experiencing that firsthand with its U.S. shingles vaccine rollout. While Shingrix sales are churning ahead of expectations

Previous page 1 2 3 Next page